So, we are starting a new week, in a new month. Last quarter of the year.
Three yrs ago we had a price surge from near $1 to a peak of near $6.
That was driven by a few things.
Expected/ speculation Aware-1, results
mangement using year end stock options & purchasing shares.
a short squeeze,
essentially causing a perfect storm for an upward spiral.
Last week, we saw a brief 20%-25% spike.
back Dec 2019, There were multiple daily spikes of 30%- 50%.
hence $1 to $6 very quickly.
Move to today:
Short % is very low. Any squeeze would be negligible.
The aware-1 , data story still lives & expected to be part of this weeks news.
The pancreatic cancer results alongside Roche are awesome , more to come with that.
With Aware-1, more or less done.now leaving the Bracelet results as a possible time lag to registration.
Bracelet results are promised Q1/ H1 of 2023.
A.N. Will be reporting this week. THAT information will set the stage for phase 3 trial parameters.
Since Dec 2019, Onc has started additional trials/ collaborations with Incyte & Merck.
The Car-t , results were presented too long ago & a partnership ( car-t), is long over due.
We had partnership speculation back in 2019.
Now multiple partnership options.....Car-t, MBc, panc & even mutiple melanoma.
talks of complete buyout?
The buyout option could happen anytime, any day.
Could be this week, next month or 5 years from now.
Point is, unless we are in the Onc board room, We do not know for sure.
it has been stated by Onc management " we are in discussions with multiple potential partners,for multiple Pela uses".
Partnership options? The bracelet trial is the most contractual. Pfizer/Onc does have in place an agreement giving Pfizer a 90 day exclusivity of the data to pen a deal.
The others ? Same potentials as a buyout.
Roche for example could come with a partnership offer tomorrow for the Panc cancer, based in FDA fast track & the over the top resUlts.
Or"........They could wait 3 months to watch the data mature.
Many many options & possibilities.
This week ( that we know of), There will be 2 announcements. Both on MBc progress.
both will be good news.The symposium is attended by 51% people outside of USA.
Now;
Point to my long jabberwalky , ONC is worth much much more than it is presently trading at.
How much & when? Depends on all of the above variables.
Myself ? I " speculate" Huge gains between now & end of March.
There will be spikes & valleys along the way.
Share price? Onc has traded since 1998 , from ..75ps to $160ps.( CDN$)
Pick a number!
The Panc cancer results alone if Onc did not have a long history, should be trading near $10ps.
analysts have an average rating of near $8 ( usd), all with caveat to modify on further update.
Have a great week all.
Wishing everyone great health & happiness in the coming festive season.
PS , I do have Share price expectations, but I won't post as even my number changes based on all of the above notations.
I will say...." much more than now"